Milda | Moderatea | Severea | OR (95% CI) | P value | |
---|---|---|---|---|---|
Number | 21 | 72 | 11 | ||
Demographic characteristics | |||||
Age (years) | 30.0 (14.5–40.5) | 44.5 (34.3–57.0) | 60.0 (45.0–72.0) | 1.07 (1.04–1.11) | < 0.001 |
Female | 8 (38.1) | 44 (61.1) | 5 (45.5) | 1.52 (0.66–3.48) | 0.326 |
BMI (kg/m2) | 21.2 (18.1–25.4) | 22.5 (20.4–25.1) | 23.4 (20.4–24.0) | 1.08 (0.96–1.22) | 0.218 |
Comorbidityb | 1 (4.8) | 15 (20.8) | 7 (63.6) | 8.09 (2.46–26.55) | < 0.001 |
Clinical symptoms | |||||
Fever | 10 (47.6) | 49 (68.1) | 10 (90.9) | 3.11(1.26–7.66) | 0.014 |
Fatigue | 0 (0) | 5 (6.9) | 1 (9.1) | 2.89(0.49–16.95) | 0.240 |
Cough | 7 (33.3) | 34 (47.2) | 5 (45.5) | 1.47(0.64–3.39) | 0.367 |
Expectoration | 2 (9.5) | 5 (6.9) | 2 (18.2) | 1.51(0.34–6.65) | 0.584 |
Shortness of breath | 1 (4.8) | 6 (8.3) | 1 (9.1) | 1.51(0.32–7.22) | 0.604 |
Diarrhoea | 1 (4.8) | 1 (1.4) | 0 (0) | 0.23(0.01–3.72) | 0.301 |
Myalgia | 1 (4.8) | 1 (1.4) | 0 (0) | 0.23(0.01–3.72) | 0.301 |
Laboratory tests | |||||
WBC count (< 3.5 × 109/L) | 1 (4.8) | 5 (6.9) | 2 (18.2) | 2.66 (0.56–12.66) | 0.220 |
Lymphocyte count (< 1.1 × 109/L) | 5 (23.8) | 31 (43.1) | 7 (63.6) | 2.73 (1.11–6.68) | 0.028 |
Eosinophil count (< 0.02 × 109/L) | 4 (19.0) | 39 (54.2) | 9 (81.8) | 5.63 (2.08–15.18) | 0.001 |
Platelet count (< 125 × 109/L) | 0 (0) | 5 (6.9) | 3 (27.3) | 7.52 (1.62–34.98) | 0.010 |
CRP (> 10 mg/L) | 2 (9.5) | 30 (41.7) | 10 (90.9) | 12.08(3.38–43.21) | < 0.001 |
LDH (> 250 U/L) | 0 (0) | 10 (14.1) | 6 (54.5) | 11.55 (3.14–42.52) | < 0.001 |
SAA (> 10 mg/L) | 11 (52.4) | 60 (83.3) | 11 (100) | 5.97 (2.13–16.67) | 0.001 |
Calcium (< 2.2 mmol/L) | 0 (0) | 19 (27.5) | 9 (81.8) | 22.69 (4.77–108.01) | < 0.001 |
Potassium (< 3.5 mmol/L) | 4 (19.0) | 20 (27.8) | 3 (27.3) | 1.38 (0.53–3.56) | 0.506 |
Phosphorus (< 0.81 mmol/L) | 0 (0) | 14 (20.3) | 3 (27.3) | 3.58 (1.10–11.6) | 0.034 |
Chlorine (< 99 mmol/L) | 0 (0) | 9 (12.5) | 2 (18.2) | 3.36 (0.85–13.24) | 0.083 |
Sodium (< 137 mmol/L) | 6 (28.6) | 25 (34.7) | 7 (63.6) | 2.17(0.89–5.28) | 0.090 |
ALB (< 40 g/L) | 3 (14.3) | 30 (41.7) | 11 (100) | 12.12(3.41–43.11) | < 0.001 |
ALB/GLB (< 1.2) | 0 (0) | 18 (25.0) | 7 (63.6) | 10.34 (2.98–35.85) | < 0.001 |
PALB (< 180 mg/L for females and < 200 mg/L for males) | 7 (35.0) | 49 (74.2) | 11 (100) | 7.70 (2.74–21.68) | < 0.001 |
TG (> 1.7 mmol/L) | 5 (23.8) | 13 (18.1) | 3 (27.3) | 0.98 (0.35–2.73) | 0.975 |
TC (< 3 mmol/L) | 0 (0) | 3 (4.2) | 2 (18.2) | 7.41 (1.16–47.21) | 0.034 |
HDL-C (< 1.1 mmol/L for females and < 1.04 mmol/L for males) | 4 (19.0) | 32 (44.4) | 8 (72.7) | 4.06 (1.57–10.52) | 0.004 |
RBP (< 23 mg/L) | 5(25.0) | 36(54.5) | 8 (80.0) | 4.20 (1.60–11.03) | 0.004 |
Apo A1 (< 1 g/L) | 10 (50.0) | 43 (65.2) | 10 (100) | 3.20 (1.26–8.15) | 0.015 |
GLB (> 40 g/L) | 0 (0) | 3 (4.2) | 0 (0) | 1.48 (0.12–17.76) | 0.756 |
FIB (> 3.5 g/L) | 4 (19.0) | 30 (41.7) | 9 (81.8) | 5.00 (1.84–13.54) | 0.002 |
D-dimer (> 0.55 mg/L) | 2 (9.5) | 12 (16.7) | 6 (54.5) | 4.91 (1.57–15.41) | 0.006 |
SaO2 (≤ 93%) | 0 (0) | 4 (5.7) | 3 (27.3) | 8.33 (1.64–42.30) | 0.011 |
PaO2/FiO2 (≤ 300 mmHg) | 0 (0) | 4 (5.7) | 3 (27.3) | 8.33 (1.64–42.30) | 0.011 |
PaCO2 (< 35 mmHg) | 1 (6.2) | 6 (8.6) | 3 (27.3) | 3.43 (0.82–14.41) | 0.093 |
ALT (> 40 U/L for females and > 50 U/L for males) | 4 (19.0) | 6 (8.3) | 2 (18.2) | 0.68 (0.19–2.41) | 0.553 |
AST (> 35 U/L for females and > 40 U/L for males) | 4 (19.0) | 8 (11.1) | 5 (45.5) | 2.16 (0.69–6.78) | 0.188 |
ADA (> 15 U/L) | 1 (5.0) | 4 (6.1) | 4 (40.0) | 7.95 (1.79–35.24) | 0.006 |
γ-GTP (> 45 U/L for females and > 60 U/L for males) | 2 (33.3) | 5 (12.2) | 1 (14.3) | 0.43 (0.08–2.46) | 0.344 |
Troponin T (> 0.014 ng/mL) | 1 (10.0) | 2(4.3) | 2 (25.0) | 3.24 (0.46–22.65) | 0.236 |
Serum iron(< 7.8umol/L for females and > 10.6 umol/L for males) | 3 (30.0) | 17 (40.5) | 5 (71.4) | 2.64 (0.79–8.78) | 0.113 |
Serum creatinine (> 81 umol/L for females and > 111 umol/L for males) | 0 (0) | 4 (5.6) | 1 (9.1) | 3.26 (0.48–21.97) | 0.225 |
Urine creatinine (< 2470umol/L for females and < 3450 umol/L for males) | 1 (9.1) | 3 (5.7) | 0 (0) | 0.49 (0.05–4.44) | 0.524 |
Reduced haemoglobin (> 7%) | 0 (0) | 4(5.7) | 3(27.3) | 8.33 (1.64–42.30) | 0.011 |
Lactate (> 1.6 mmol/L) | 4(25.0) | 14(20.0) | 3(27.3) | 1.01 (0.35–2.94) | 0.982 |
IgG (> 16 g/L) | 0 (0) | 3 (5.4) | 1 (12.5) | 4.45 (0.53–37.11) | 0.168 |
GPDA (< 44 U/L) | 0 (0) | 1 (1.5) | 0 (0) | 1.51 (0.02–105.39) | 0.849 |
FFA (> 769 umol/L) | 1 (5.0) | 3 (4.5) | 0 (0) | 0.60 (0.08–4.67) | 0.625 |
β2-microglobulin (> 3 mg/L) | 0 (0) | 6 (8.5) | 1 (9.1) | 2.65 (0.51–13.83) | 0.248 |
Uric acid (< 154.7umol/L for females and < 208.3 umol/L for males) | 1 (4.8) | 7 (9.7) | 2 (18.2) | 2.39 (0.58–9.89) | 0.230 |
eGFR (< 90 ml/min) | 1 (4.8) | 16 (22.2) | 3 (27.3) | 2.66 (0.89–7.96) | 0.079 |
DBIL (> 6.84 umol/L) | 5 (23.8) | 15 (20.8) | 5 (45.5) | 1.64 (0.61–4.37) | 0.324 |